Street News: JPM’s $2B Loss a Factor in Downgrade
Street News: JPM’s B Loss a Factor in Downgrade – June 22 (Bloomberg) — Bloomberg’s Scarlet Fu reports on today’s top news including the FDA rejects Johnson & Johnson and Bayer on a bid to use blood thinnin…